Overview

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

Status:
Completed

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to investigate the protective effects of sitagliptin on β cell function in patients with adult-onset latent autoimmune diabetes (LADA) and its mechanisms.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

European Foundation for the Study of Diabetes

Collaborators:

Chinese Medical Association
Eli Lilly and Company

Treatments:

Sitagliptin Phosphate